Scaling the Phoenix House Florida MAT Program Through Precision Medicine and Pharmacogenomics

The core of this project is a strategic expansion of the Phoenix House Florida Medication Assisted Treatment (MAT) program, which aims to bridge the gap between traditional behavioral therapy and modern biotechnology by providing data-driven, personalized treatment for individuals struggling with substance use disorder (SUD). Situated in the Tampa Bay area, the project’s primary objective is to empower long-term recovery through the integration of pharmacogenomics (PGx) and evidence based clinical care, offering the community a scientifically superior alternative to standard outpatient treatment.